Skip to content
Discovery and patent for Can-Fite and Univo: Cannabis-based formulations for the treatment of a range of illnesses
UNV entered into a binding agreement with SuperPharm for the sale of more than 1.7 tons of medical cannabis in 2020
Permanent GMP-IMC certification awarded for medical cannabis product R&D laboratory
Subsidiary UNV has entered into an agreement for the sale of medical cannabis products to another two pharmacies
Approval received from the Ministry of Health to carry out R&D on cannabis-based medical formulations
Mor Investments to invest NIS 3 million in Univo in consideration for a (non-negotiable) right to receive 1.25 million shares; amount may rise to NIS 5.25 million
Binding agreement for the sale of medical cannabis in a quantity of 250 kg to 2 tons to the Medi-Plus pharmacy chain
Sales to medical cannabis patients commenced, revenues expected in Q4, intention to expand the distribution system
Receipt of a license for distribution and transportation of medical cannabis products.
Agreement for the manufacture of medical cannabis-based products for Teva Adir
Copyright © 2019 UNV Medicine LTD. All rights reserved. This information—including product information—is intended only for residents of Israel. The products discussed herein may have different labeling in different countries.